Are you a new member? Sign up now
Login area
| Sign up
close
AVASTIN - 400mg - 1 x 16ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FG01 | BioTech | Bevacizumab - 400mg | 6110 | 167517/10 | AVASTIN | 400mg | 1 x 16ml | Injectable concentrated solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 75,875,312 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 12/12/20 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 5555 | 221326/08 | AVASTIN | 400mg/16ml | 1 x 16ml | Injectable concentrated solution | Infusion | Omnipharma | F. Hoffmann La Roche Manufacturing Site Kaiseraugst | Switzerland | 75,875,312 L.L | 2.44 | E2 | 12/12/20 | 0 | ||
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 10325 | 175319/1 | STIVANT | 400mg/16ml | 1x16ml | Injectable concentrate for solution | Infusion | Lebiran SARL | Aryogen Pharmed | Iran | 27,359,527 L.L | 10.71 | E1 | Aryogen Pharmed | Iran | 12/12/20 | 0 |
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 10249 | 100220/1 | ZIRABEV | 400mg/16ml | 1x16ml | Injectable solution | Infusion | Droguerie Fattal S.A.L. | Pharmacia & Upjohn Company LLC | USA | 49,965,229 L.L | 10.71 | E1 | Pfizer Inc | USA | 12/12/20 | 0 |
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 10520 | 100620/1 | MVASI | 400mg/16ml | 1x16ml | Injectable concentrate for solution | Infusion | Mersaco | Amgen Manufacturing Ltd | USA | 58,035,926 L.L | 10.71 | E1 | Amgen Technology (Ireland) Unlimited Company | Ireland | 12/12/20 | 0 |
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 10794 | 96821/1 | BIVASTINA 400 | 400mg/16ml | 2x16ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 142,487,946 L.L | 2.44 | E2 | 12/12/20 | 0 | ||
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 11596 | 106923/1 | BEVACIREL | 400mg/16ml | 1x16ml | Injectable solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | 49,744,595 L.L | 10.71 | E1 | Reliance Life Sciences pvt Ltd | India | 12/12/20 | 0 |
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 11667 | 6524/1 | BIVASTINA 400 | 400mg/16ml | 1x16ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 77,844,379 L.L | 10.71 | E1 | 12/12/20 | 0 | ||
| L01FG01 | BioTech | Bevacizumab - 400mg/16ml | 11596/388 | 106923/1 | BEVACIREL | 400mg/16ml | 1x16ml | Injectable solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | L.L | 10.71 | E1 | Reliance Life Sciences pvt Ltd | India | 05/02/20 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024